🚨 PhD opportunity at @CCG_UCL!
Build AI & computational tools to catch ecDNA in single cells: rogue DNA circles that let cancer shapeshift & beat therapy
With Mariam & @BenjaminWerner_ via the @CRUKCOLcentre at @uclcancer Black Leaders in Cancer PhD
👇
https://t.co/erF3Knc76b
How do cancers emerge from healthy tissue? In @Nature today: leukaemia evolving in yearly blood samples up to 15 yrs before AML. First driver by age 20; each new driver multiplies growth 2–3×. A remarkably simple set of mathematical rules recapitulate it.
https://t.co/S0GVv97hyE
⏳ Just 2 weeks left to apply!
Know a prospective PhD student of Black heritage excited by single-cell genomics, AI & cancer evolution? 🧬
Join us to uncover how ecDNA helps tumours shapeshift & beat therapy, through the CRUK Black Leaders in Cancer Programme
Please share 🙏👇
🚨 PhD opportunity at @CCG_UCL!
Build AI & computational tools to catch ecDNA in single cells: rogue DNA circles that let cancer shapeshift & beat therapy
With Mariam & @BenjaminWerner_ via the @CRUKCOLcentre at @uclcancer Black Leaders in Cancer PhD
👇
https://t.co/erF3Knc76b
Who? 🧑💻
Bioinformatics, CS, maths, physics, or any quantitative background. You should be excited by algorithms & cancer evolution. Sequencing experience is a bonus, not a must.
Programme & eligibility 👉 https://t.co/ptMqODvhC4
Please share 🙏
🚨 PhD opportunity at @CCG_UCL!
Build AI & computational tools to catch ecDNA in single cells: rogue DNA circles that let cancer shapeshift & beat therapy
With Mariam & @BenjaminWerner_ via the @CRUKCOLcentre at @uclcancer Black Leaders in Cancer PhD
👇
https://t.co/erF3Knc76b
The twist 🧠
The same single-cell data also reads out replication timing, a window into each cell's epigenetic state. You'll link ecDNA to the cell states and plasticity that drive resistance, beyond the amplified oncogenes themselves
👇
https://t.co/jNg2WzLgcU
Register today for the Cancer Research UK Lung Cancer Centre of Excellence Conference, 4-6 November 2026, Manchester, UK. Hear from some of the world's leading researchers and clinicians on the latest in lung cancer research. See you there. https://t.co/ILVHLdozl7
👉 Dr. Lisa Derosa calls on you to be part of the mission shaping the next generation in oncology. Join the global community at the Molecular Analysis for Precision Oncology Congress 2026 in London, 10–11 September.
⏰ Register by 8 July and save! #MAP2026#esmomeetings
🔗 https://t.co/LCF4jPtKlv
On a personal note, it was incredibly special to finally wear the gown from my own graduating university, @unimib. Thanks @ucl for this! 🇮🇹🎓
A wonderful reminder of where my pathway started at @unimib Informatica, and of @BonizzoniPaola who, in turn, supported me at the time 🙏
🎓 ABSOLUTELY BURSTING WITH PRIDE!
Huge congrats to our @CCG_UCL first doctoral graduates: Dr @Rija_Zaidi_, Dr @abi_bunkum & Dr @ojlucas! 🎉
Whatever pathways they choose next, I have no doubt these brilliant minds will lead critical advances in our society—we're all so lucky!✨
🫁 What if lung cancer metastases are not just destinations, but active sources of further spread?
A new Nature study from TRACERx–PEACE offers one of the most detailed evolutionary maps of NSCLC metastasis to date.
Using 501 longitudinally collected primary and metastatic tumor samples from 24 patients, researchers reconstructed how lung cancer spread from diagnosis to death, and the findings challenge the simple “primary tumor → metastasis” model.
Key signals:
🧬 62.5% of patients had multiple primary tumor subclones that seeded distinct metastases
🔁 60% of sampled metastases were seeded by other metastases
⏳ Metastases present for longer were more likely to seed further disease
📍 Most metastatic migrations stayed within the same anatomical cavity
⚠️ Subclones that escaped the thorax were enriched for chromosomal instability
The message is clear: metastatic NSCLC is not static. It is spatially organized, genetically diverse, and continuously evolving.
This study does not immediately change clinical practice, but it gives a powerful biological rationale for better relapse monitoring, deeper metastatic profiling, and carefully selected local treatment strategies.
https://t.co/i8XjSoDUL0
@SonyaHessey@AMIHuebner @HaaseKerstin @KristianaGrigo4@wingkinliu@ojlucas@FVasilopoulou@ProfSiowMingLee@DionysisPastos@MatthewGKrebs@LeQuesneLab@dean_fennell@crispinhiley@ZaccaSimo@NickyMcGranahan@CharlesSwanton
#LungCancer #NSCLC #TRACERx #PEACEStudy #Metastasis #CancerEvolution #TumorHeterogeneity #ChromosomalInstability #PrecisionOncology #ThoracicOncology #OncoDaily #OncoDailyLung
🚨 Huge honour to have helped supervise this landmark PEACE study!
New insights into metastasis + a unique dataset of unprecedented resolution on metastatic evolution and dissemination that we hope will drive future advances
🙏 @CR_UK@CRUKresearch.
Please take a look 👇
Through the integration of the #PEACE autopsy programme, which allows high breadth metastasis sampling, with the #TRACERx lung study, we collected and studied 501 primary and metastatic tumour samples from 24 patients with #NSCLC enrolled in the both studies. 2/9
Congratulations to @CharlesSwanton, Mariam Jamal-Hanjani and colleagues on their fascinating analysis of the evolution of lung cancer metastasis published in @Nature!
https://t.co/96aszH5GBW
Using MACHINA from @benjraphael's lab to infer metastatic migration patterns, we found that NSCLC primaries had multiple seeding subclones more often than a single seeding subclone. 4/9
Through the integration of the #PEACE autopsy programme, which allows high breadth metastasis sampling, with the #TRACERx lung study, we collected and studied 501 primary and metastatic tumour samples from 24 patients with #NSCLC enrolled in the both studies. 2/9
Online here: https://t.co/nzzWChWPkD
Open access here: https://t.co/MEUA5HUeGx
Key supporters of this work are @CR_UK , @CRUKLungCentre , @UCLHresearch alongside many others